HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
China flag China · Delayed Price · Currency is CNY
10.96
+0.05 (0.46%)
At close: Feb 27, 2026

SHA:600829 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
6,3564,3494,5353,7003,8974,303
Market Cap Growth
52.43%-4.09%22.57%-5.06%-9.43%8.80%
Enterprise Value
6,4694,4994,6543,9124,5754,515
Last Close Price
10.967.507.626.226.557.09
PE Ratio
53.3420.3915.5213.9914.0529.62
PS Ratio
0.620.430.440.380.420.54
PB Ratio
2.121.511.651.511.772.16
P/TBV Ratio
2.141.521.661.521.802.19
P/FCF Ratio
197.6940.5014.6512.30--
P/OCF Ratio
141.8937.6813.6212.04--
EV/Sales Ratio
0.630.450.450.410.490.56
EV/EBITDA Ratio
25.2214.1010.789.6910.4816.26
EV/EBIT Ratio
32.8515.0011.3110.2111.0817.86
EV/FCF Ratio
201.2241.8915.0413.00--
Debt / Equity Ratio
0.250.310.370.520.600.31
Debt / EBITDA Ratio
2.862.502.162.842.802.20
Debt / FCF Ratio
22.838.383.294.22--
Net Debt / Equity Ratio
0.04-0.07-0.110.040.240.10
Net Debt / EBITDA Ratio
0.53-0.63-0.680.221.210.69
Net Debt / FCF Ratio
3.53-1.86-0.950.29-2.15-8.28
Asset Turnover
1.451.381.441.401.461.39
Inventory Turnover
8.638.298.598.027.486.26
Quick Ratio
1.371.331.271.221.151.11
Current Ratio
1.681.621.531.481.421.43
Return on Equity (ROE)
4.06%7.57%11.22%11.36%13.19%7.55%
Return on Assets (ROA)
1.75%2.57%3.55%3.47%4.05%2.74%
Return on Invested Capital (ROIC)
4.63%8.62%12.23%11.12%12.97%7.96%
Return on Capital Employed (ROCE)
6.30%9.90%14.20%14.60%17.30%11.90%
Earnings Yield
1.87%4.90%6.44%7.15%7.12%3.38%
FCF Yield
0.51%2.47%6.83%8.13%-6.29%-0.54%
Dividend Yield
--1.89%--1.69%
Payout Ratio
21.47%75.22%8.43%11.53%12.86%2.93%
Buyback Yield / Dilution
0.02%0.01%-0.01%0.00%0.20%-0.20%
Total Shareholder Return
0.02%0.01%1.88%0.00%0.20%1.49%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.